Phase II Study of IO102-IO103 and Pembrolizumab (KEYTRUDA®) Before and After Surgery for Patients with Resectable Tumors | Clinical Trial

Phase II Study of IO102-IO103 and Pembrolizumab (KEYTRUDA®) Before and After Surgery for Patients with Resectable Tumors | Clinical Trial | Right2Hope